Biotech Acquisition Company

Biotech Acquisition Company

Share · KYG1125A1085 · BIOT (XNAS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Biotech Acquisition Company
No Price
Company Profile for Biotech Acquisition Company Share
Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

Company Data

Name Biotech Acquisition Company
Company Biotech Acquisition Company
Symbol BIOT
Primary Exchange XNAS NASDAQ
ISIN KYG1125A1085
Asset Class Share
Sector Financial Services
Industry Shell Companies
CEO Michael Shleifer
Country United States of America
Currency USD
Employees -
Address 545 West 25th Street, 10001 New York City
IPO Date 2021-03-18

Ticker Symbols

Name Symbol
NASDAQ BIOT
More Shares
Investors who hold Biotech Acquisition Company also have the following shares in their portfolio:
AUSTRALIA & NEW ZEALAND BANKING GROUP LD CALL ZERO CPN NTS 08/03/47
AUSTRALIA & NEW ZEALAND BANKING GROUP LD CALL ZERO CPN NTS 08/03/47 Bond
CCO S 17/28 REGS
CCO S 17/28 REGS Bond